Reference

Papers. Original Publications.

The industry’s widely recognized gold standard encompasses a diverse range of high-quality biomedical research publications and robust clinical evidence that thoroughly report and analyze the most effective options available for optimal infusion care practices.

Intravenous Immunoglobulins As First-Line Treatment In Idiopathic Inflammatory Myopathies: A Pilot Study

Controlled Studies with High-Dose Intravenous Immunoglobulin in the Treatment of Dermatomyositis, Inclusion Body Myositis, and Polymyositis

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Efficacy and safety of Vyepti (eptinezumab) in patients with chronic migraine

Update on the use of immunoglobulin in human disease: A review of evidence

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial

Long-term effects of intravenous immunoglobulin in CIDP

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Polyradiculoneuropathy

Intravenous Immunoglobulin Therapy Treat Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy